WATCH today

Mast Cell Activation Syndrome

Access

12 months

Format

Online Webinar

Duration

1 hour

Presenter

Beth O’Hara

Developing an understanding of complex, chronic cases of Mast Cell Activation Syndrome (MCAS) is essential as patients with MCAS often remain undiagnosed and symptomatic for decades. The prevalence of MCAS is expected to rise significantly in the next decade due to COVID-19 (1).

Understanding this disorder is essential to restoring wellness in chronic illness. Building this knowledge dramatically increases clinical outcomes in pain syndromes, and fatigue presentations.

First reported in 2007, MCAS is a multifactorial, usually somatically polygenic chronic multisystem disorder with inflammatory and allergic themes and has an estimated prevalence of 17% (2).


Find out all you need to know about how MCAS influences heath including 3 of the top presentations within clinical practice – pain, migraine, and fatigue.

We urgently need to develop clinical understanding of how to reduce the long-term impact of this growing health crisis through integrative and environmental health interventions. Reduce the impact of MCAS on a person’s quality of life.

Join internationally renowned Beth O’Hara, a successful functional naturopathic clinician and co-founder of the Mast Cell 360 Program, a powerful, holistic health program for MCAS.

Find out why:
  • People who have MCAS go undiagnosed
  • How MCAS can be supported by adopting a holistic approach to health 

This webinar is Part 1 of 3 with Beth O’Hara, her other two presentations are both available in the Optimising Immune Function learning module. 

MEET YOUR PRESENTER

Beth O’Hara

BA(Psych), MA, DipNat
Beth O’Hara is a Functional Naturopath, specialising in complex, chronic cases of Mast Cell Activation Syndrome, Histamine Intolerance, and Mold Toxicity. She is the founder and owner of Mast Cell 360, a Functional Naturopathy Practice designed to look at all factors surrounding health conditions – genetic, epigenetic, biochemical, physiological, environmental, and emotional.

She designed Mast Cell 360 to be the kind of practice she wished had existed when she was severely ill with Mast Cell Activation Syndrome, Histamine Intolerance, Mold Toxicity, Neural Inflammation, Lyme, Fibromyalgia, and Chronic Fatigue. Her mission today is to be a guiding light for others with Mast Cell Activation Syndrome, Histamine Intolerance and these related conditions in their healing journeys.

Through her Mast Cell 360 Root Cause process, she discovers the unique root factors affecting each of her clients’ health issues, building personalised, effective roadmaps for healing. She holds a doctorate in Functional Naturopathy, a Master’s degree in Marriage and Family Therapy and a Bachelor’s degree in Physiological Psychology. She is certified in Functional Genomic Analysis and is a Research Adviser for the Nutrigenetic Research Institute. She presents at Functional Medicine Conferences on Mast Cell Activation Syndrome and Histamine Intolerance as well as the use of genetics and biochemistry in addressing chronic health conditions.
References
  1. Weinstock, L. B., Brook, J. B., Walters, A. S., Goris, A., Afrin, L. B., & Molderings, G. J. (2021). Mast cell activation symptoms are prevalent in Long-COVID. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 112, 217–226. https://doi.org/10.1016/j.ijid.2021.09.043
  2. Afrin, L. B., Ackerley, M. B., Bluestein, L. S., Brewer, J. H., Brook, J. B., Buchanan, A. D., Cuni, J. R., Davey, W. P., Dempsey, T. T., Dorff, S. R., Dubravec, M. S., Guggenheim, A. G., Hindman, K. J., Hoffman, B., Kaufman, D. L., Kratzer, S. J., Lee, T. M., Marantz, M. S., Maxwell, A. J., McCann, K. K., … Molderings, G. J. (2020). Diagnosis of mast cell activation syndrome: a global “consensus-2”. Diagnosis (Berlin, Germany), 8(2), 137–152. https://doi.org/10.1515/dx-2020-0005